New Jersey S1965 codifies regulations on pharmaceutical services in long-term care facilities and mandates conflict-of-interest prevention.
New Jersey S1965 codifies current Department of Health regulations concerning the provision of pharmaceutical services in long-term care facilities. It mandates that each facility have an interdisciplinary pharmacy and therapeutics committee, consisting of the administrator, a nursing staff representative, and the facility's consultant pharmacist, among others. The bill also requires facilities to appoint a consultant pharmacist who must avoid conflicts of interest with the director of pharmaceutical services or the pharmacist provider.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.